Axsome Therapeutics, Inc.: Istoricul versiunilor

29 septembrie 2024

• actualăprec 12:4829 septembrie 2024 12:48‎ 127.0.0.1 discuție‎ 1.398 de octeți +12‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 15:4018 septembrie 2024 15:40‎ Admin discuție contribuții‎ 1.386 de octeți +1.386‎ Pagină nouă: Pagina dedicata companiei Axsome Therapeutics, Inc. listata cu simbolul US.AXSM ==Descriere companie== Axsome Therapeutics, Inc. (www.axsome.com) is a biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders. The Company's core CNS portfolio includes five product candidates, which includes AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is an oral N-methyl-D-aspartate (NMDA) receptor antagonist...